Literature DB >> 25354496

The Physiology of BDNF and Its Relationship with ADHD.

De-Yi Liu1, Xue-Mei Shen2, Fang-Fen Yuan2, Ou-Yang Guo1, Yan Zhong3, Jian-Guo Chen4, Ling-Qiang Zhu5, Jing Wu6.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a major neurotrophin in the central nervous system that plays a critical role in the physiological brain functions via its two independent receptors: tropomyosin-related kinase B (TrkB) and p75, especially in the neurodevelopment. Disrupting of BDNF and its downstream signals has been found in many neuropsychological diseases, including attention-deficit hyperactivity disorder (ADHD), a common mental disorder which is prevalent in childhood. Understanding the physiological functions of BDNF during neural development and its potential relationship with ADHD will help us to elucidate the possible mechanisms of ADHD and to develop therapeutic approaches for this disease. In this review, we summarized the important literatures for the physiological functions of BDNF in the neurodevelopment. We also performed an association study on the functional genetic variation of BDNF and ADHD by a case-control study in the Chinese mainland population and revealed the potential correlation between BDNF and ADHD which needs further research to confirm.

Entities:  

Keywords:  ADHD; BDNF; Neural development; Val66Met

Mesh:

Substances:

Year:  2014        PMID: 25354496     DOI: 10.1007/s12035-014-8956-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  101 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2.

Authors:  Fernando Aguado; Maria A Carmona; Esther Pozas; Agustín Aguiló; Francisco J Martínez-Guijarro; Soledad Alcantara; Victor Borrell; Rafael Yuste; Carlos F Ibañez; Eduardo Soriano
Journal:  Development       Date:  2003-04       Impact factor: 6.868

Review 3.  Regulation of brain neurotrophin expression by physiological activity.

Authors:  C M Gall
Journal:  Trends Pharmacol Sci       Date:  1992-11       Impact factor: 14.819

4.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

5.  Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor.

Authors:  S J Mowla; H F Farhadi; S Pareek; J K Atwal; S J Morris; N G Seidah; R A Murphy
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

6.  NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression.

Authors:  P C Maisonpierre; L Belluscio; B Friedman; R F Alderson; S J Wiegand; M E Furth; R M Lindsay; G D Yancopoulos
Journal:  Neuron       Date:  1990-10       Impact factor: 17.173

7.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

Authors:  Félicien Karege; Michèle Schwald; Mbaye Cisse
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

8.  Nitric oxide regulates BDNF release from nodose ganglion neurons in a pattern-dependent and cGMP-independent manner.

Authors:  Hui-ya Hsieh; Carolyn L Robertson; Anke Vermehren-Schmaedick; Agnieszka Balkowiec
Journal:  J Neurosci Res       Date:  2010-05-01       Impact factor: 4.164

Review 9.  Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity.

Authors:  D Suri; V A Vaidya
Journal:  Neuroscience       Date:  2012-09-09       Impact factor: 3.590

10.  Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3.

Authors:  B Knüsel; J W Winslow; A Rosenthal; L E Burton; D P Seid; K Nikolics; F Hefti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

View more
  28 in total

1.  Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm.

Authors:  Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-12       Impact factor: 4.147

2.  Developmental nicotine exposure elicits multigenerational disequilibria in proBDNF proteolysis and glucocorticoid signaling in the frontal cortices, striata, and hippocampi of adolescent mice.

Authors:  Jordan M Buck; Heidi C O'Neill; Jerry A Stitzel
Journal:  Biochem Pharmacol       Date:  2019-08-09       Impact factor: 5.858

3.  Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Maryam Rafeiy-Torghabeh; Amir Ashraf-Ganjouei; Kamyar Moradi; Sayna Bagheri; Mohammad-Reza Mohammadi; Shahin Akhondzadeh
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-05-24       Impact factor: 4.785

4.  BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology.

Authors:  Isabel Cubero-Millán; María-José Ruiz-Ramos; Antonio Molina-Carballo; Sylvia Martínez-Serrano; Luisa Fernández-López; Irene Machado-Casas; Pilar Tortosa-Pinto; Aida Ruiz-López; Juan-de-Dios Luna-Del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Psychopharmacology (Berl)       Date:  2016-11-03       Impact factor: 4.530

Review 5.  Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review.

Authors:  Javier Quintero; José R Gutiérrez-Casares; Cecilio Álamo
Journal:  Neurol Ther       Date:  2022-08-11

6.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

Review 7.  Targeting MicroRNAs Involved in the BDNF Signaling Impairment in Neurodegenerative Diseases.

Authors:  Hwa Jeong You; Jae Hyon Park; Helios Pareja-Galeano; Alejandro Lucia; Jae Il Shin
Journal:  Neuromolecular Med       Date:  2016-05-21       Impact factor: 3.843

8.  Systematic review and meta-analysis: relationships between attention-deficit/hyperactivity disorder and urinary symptoms in children.

Authors:  Behrang Mahjani; Lotta Renström Koskela; Christina Gustavsson Mahjani; Magdalena Janecka; Anita Batuure; Christina M Hultman; Abraham Reichenberg; Joseph D Buxbaum; Olof Akre; Dorothy E Grice
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-02-26       Impact factor: 4.785

9.  Methotrexate Neurotoxicity Is Related to Epigenetic Modification of the Myelination Process.

Authors:  Yu-Chieh Chen; Jiunn-Ming Sheen; Su-Chen Wang; Mei-Hsin Hsu; Chih-Cheng Hsiao; Kow-Aung Chang; Li-Tung Huang
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 10.  DNA methylome perturbations: an epigenetic basis for the emergingly heritable neurodevelopmental abnormalities associated with maternal smoking and maternal nicotine exposure†.

Authors:  Jordan M Buck; Li Yu; Valerie S Knopik; Jerry A Stitzel
Journal:  Biol Reprod       Date:  2021-09-14       Impact factor: 4.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.